Pomerantz LLP Appointed Lead Counsel in Domo, Inc. Securities Litigation

On April 7, 2020, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against Domo, Inc., brought on by concerns that Domo and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.

Pomerantz Scores Major Victory with Class Certification for Mylan Shareholders

On April 6, 2020, Pomerantz succeeded in both defeating the Defendants’ motion to dismiss the third amended complaint against Mylan Pharmaceuticals and in getting the class certified by Judge Oetken in the Southern District of New York.

Pomerantz LLP Appointed Lead Counsel in Forescout Technologies, Inc.

On March 23, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Forescout Technologies, Inc.

Pomerantz LLP Appointed Lead Counsel in Twitter, Inc. Securities Litigation

On February 12, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Twitter, Inc, regarding its misrepresentation of “fixes” to user choice settings, which adversely affected its ability to deliver monetized advertisements.

Pomerantz LLP Appointed Lead Counsel in Canopy Growth Corporation Securities Litigation

On February 11, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Canopy Growth Corporation, alleging that the Company issued false and/or misleading statements …

Pomerantz LLP Appointed Lead Counsel in PG&E Corporation Securities Litigation

On February 3, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against PG&E Corporation, alleging that PG&E’s new, “enhanced” wildfire prevention and safety protocols were misrepresented as adequate …

Pomerantz LLP Appointed Lead Counsel in Zynerba Pharmaceuticals, Inc. Securities Litigation

On January 10, 2020, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against Zynerba Pharmaceuticals, Inc., regarding allegations that Zynerba failed to disclose details discovered in trials of its transdermal CBD gel product, Zygel.

Pomerantz LLP Appointed Lead Counsel in Match Group, Inc. Securities Litigation

On January 7, 2020, Pomerantz LLP was appointed Lead Counsel in a class action lawsuit against Match Group, Inc., regarding allegations that the Company failed to disclose adverse facts about its practice of bating customers of its dating products with fake love interest ads …

Pomerantz LLP Appointed Lead Counsel in Eldorado Resorts, Inc. Securities Litigation

On January 2, 2020, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Eldorado Resorts, Inc., alleging that several of the Company’s officers knowingly disregarded Eldorado’s Code of Ethics and Business Conduct.

Pomerantz Law Firm Files a Securities Fraud Lawsuit Against Danske Bank Relating to Money Laundering Scheme

On December 27, 2019, Pomerantz LLP announced that it has filed a securities fraud lawsuit on behalf of several dozen institutional investors in conjunction with the ISAF-Danske Coalition (International Securities Associations and Foundations Management Company for Damaged Danske Investors).

Pomerantz LLP Appointed Lead Counsel in Altria Group, Inc. Securities Litigation

On December 30, 2019, Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Altria Group and certain of its senior officers concerning the nature of its investment in JUUL Labs, Inc in December, 2018.

Pomerantz LLP Appointed Lead Counsel in International Flavors & Fragrances Inc. Securities Litigation

On December 26, 2019, Pomerantz LLP was appointed Lead Counsel in a securities class action lawsuit against International Flavors & Fragrances, Inc, in the United States District Court for the Southern District of New York.

Pomerantz LLP Appointed Lead Counsel in Sarepta Therapeutics Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action against Sarepta Therapeutics, Inc. and certain of its senior officers for violation of the federal securities laws.

Pomerantz LLP Appointed Lead Counsel in Community Health Systems, Inc. Securities Litigation

On November 20, 2019, Pomerantz LLP was appointed Lead Counsel in Padilla v. Community Health Systems, Inc., a securities class action litigation in the Middle District of Tennessee.

Pomerantz Appointed Lead Counsel in Aclaris Therapeutics Securities Litigation

Pomerantz LLP was appointed lead counsel in a securities litigation class action lawsuit against Aclaris Therapeutics, Inc.

Jeremy Lieberman Interviewed by Lawdragon

Pomerantz Managing Partner featured on Lawdragon. Read here!

Pomerantz LLP Appointed Lead Counsel in Intelligent Systems Corporation Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit against Intelligent Systems Corporation.

Pomerantz LLP Appointed Lead Counsel in Fred's, Inc. Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action lawsuit aganist Fred’s Inc.

Michael Grunfeld Honored as a Law360 Rising Star

Pomerantz is pleased to announce that Partner Michael Grunfeld, has been recognized as a Law360 Rising Star. This prestigious award is given to a select few top litigators under 40 years old “whose legal accomplishments transcend their age.”

Read more about Michael’s recognition here!

Pomerantz LLP Appointed Lead Counsel in CBL & Associates Properties, Inc. Securities Litigation

Pomerantz LLP was appointed Lead Counsel in a securities litigation class action suit against CBL & Associates Properties.